Your browser doesn't support javascript.
COVID-19 and Avoiding Ibuprofen. How Good Is the Evidence?
Kutti Sridharan, Gurusaravanan; Kotagiri, Rajesh; Chandiramani, Vijay H; Mohan, Babu P; Vegunta, Rathnamitreyee; Vegunta, Radhakrishna; Rokkam, Venkata R P.
  • Kutti Sridharan G; Department of Internal Medicine, Banner University Medical Center, University of Arizona, Tucson, AZ.
  • Kotagiri R; Department of Internal Medicine, Banner University Medical Center, University of Arizona, Tucson, AZ.
  • Chandiramani VH; Department of Internal Medicine, Banner University Medical Center, University of Arizona, Tucson, AZ.
  • Mohan BP; Department of Internal Medicine, Banner University Medical Center, University of Arizona, Tucson, AZ.
  • Vegunta R; Department of Internal Medicine, Westchester Medical Center, Valhalla, NY.
  • Vegunta R; Department of Oncology, Sanford Health/University of North Dakota School of Medicine and Health Sciences, Fargo, ND.
  • Rokkam VRP; Department of Internal Medicine, Banner University Medical Center, University of Arizona, Tucson, AZ.
Am J Ther ; 27(4): e400-e402, 2020.
Article in English | MEDLINE | ID: covidwho-194451
ABSTRACT
Ibuprofen is an over-the-counter medication that is used widely for the treatment of pain and fever during COVID-19 pandemic. A concern was raised regarding the safety of ibuprofen use because of its role in increasing ACE2 levels within the Renin-Angiotensin-Aldosterone system. ACE2 is the coreceptor for the entry of SARS-CoV-2 into cells, and so, a potential increased risk of contracting COVID-19 disease and/or worsening of COVID-19 infection was feared with ibuprofen use. However, available data from limited studies show administration of recombinant ACE2 improves lung damage caused by respiratory viruses, suggesting ibuprofen use may be beneficial in COVID-19 disease. At this time, there is no supporting evidence to discourage the use of ibuprofen.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Anti-Inflammatory Agents, Non-Steroidal / Ibuprofen / Coronavirus Infections Type of study: Prognostic study Topics: Long Covid Limits: Animals / Humans Language: English Journal: Am J Ther Journal subject: Therapeutics Year: 2020 Document Type: Article Affiliation country: MJT.0000000000001196

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Anti-Inflammatory Agents, Non-Steroidal / Ibuprofen / Coronavirus Infections Type of study: Prognostic study Topics: Long Covid Limits: Animals / Humans Language: English Journal: Am J Ther Journal subject: Therapeutics Year: 2020 Document Type: Article Affiliation country: MJT.0000000000001196